Search research articles
Contact Us
Filters
Showing results (411-420 of 469) with videos related to
Page
of 47
Sort By:
Frontiers in Oncology
|
June 20, 2022
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy
Abhishek Mahajan, Ankur Chand, Ujjwal Agarwal, et al.
JCO Global Oncology
|
April 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial
Vanita Noronha, Minit Shah, Akhil Kapoor, et al.
Cancer Epidemiology
|
August 2, 2024
Prevalence and types of cancer in older Indians: A multicentric observational study across 17 institutions in India
Vanita Noronha, Abhijith Rajaram Rao, Anupa Pillai, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy
Maurice Pérol, Tudor-Eliade Ciuleanu, Oscar Arrieta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 2023
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
Sarbani G Laskar, Devendra Chaukar, Mandar Deshpande, et al.
South Asian Journal of Cancer
|
August 17, 2018
Patterns of epidermal growth factor receptor testing across 111 tertiary care centers in India: Result of a questionnaire-based survey
Kumar Prabhash, Purvish M Parikh, Senthil J Rajappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer
Vijay M Patil, Vanita Noronha, Amit Joshi, et al.
Head & Neck
|
March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis
Sarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
International Journal of Cancer
|
August 2, 2024
Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer
Vanita Noronha, Vijay Maruti Patil, Nandini Menon, et al.
Oncotarget
|
February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Vanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 469) with videos related to
Sort By:
Page
of 47
Frontiers in Oncology
|
June 20, 2022
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy
Abhishek Mahajan, Ankur Chand, Ujjwal Agarwal, et al.
JCO Global Oncology
|
April 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial
Vanita Noronha, Minit Shah, Akhil Kapoor, et al.
Cancer Epidemiology
|
August 2, 2024
Prevalence and types of cancer in older Indians: A multicentric observational study across 17 institutions in India
Vanita Noronha, Abhijith Rajaram Rao, Anupa Pillai, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy
Maurice Pérol, Tudor-Eliade Ciuleanu, Oscar Arrieta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 2023
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity
Sarbani G Laskar, Devendra Chaukar, Mandar Deshpande, et al.
South Asian Journal of Cancer
|
August 17, 2018
Patterns of epidermal growth factor receptor testing across 111 tertiary care centers in India: Result of a questionnaire-based survey
Kumar Prabhash, Purvish M Parikh, Senthil J Rajappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer
Vijay M Patil, Vanita Noronha, Amit Joshi, et al.
Head & Neck
|
March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis
Sarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
International Journal of Cancer
|
August 2, 2024
Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer
Vanita Noronha, Vijay Maruti Patil, Nandini Menon, et al.
Oncotarget
|
February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Vanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Page
of 47